Current Pharmaceutical Design
About
In The Last Decade
Current Pharmaceutical Design
9.1k papers receiving 267.0k citations
Fields of papers published in Current Pharmaceutical Design
This network shows the impact of papers published in Current Pharmaceutical Design. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Current Pharmaceutical Design.
Countries where authors publish in Current Pharmaceutical Design
This map shows the geographic impact of research published in Current Pharmaceutical Design. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Current Pharmaceutical Design with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Current Pharmaceutical Design more than expected).
- Natural and Synthetic Coumarin Derivatives with Anti-Inflammatory / Antioxidant Activities (2004)
- Studies on Coumarins and Coumarin-Related Compounds to Determine their Therapeutic Role in the Treatment of Cancer (2004)
- Smart Stimuli Sensitive Nanogels in Cancer Drug Delivery and Imaging: A Review (2013)
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.